Methylene blue induces an analgesic effect by significantly decreasing neural firing rates and improves pain behaviors in rats
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Seung Won | - |
dc.contributor.author | Moon, Sun Wook | - |
dc.contributor.author | Park, Jin Sung | - |
dc.contributor.author | Suh, Hye Rim | - |
dc.contributor.author | Han, Hee Chul | - |
dc.date.accessioned | 2021-08-30T02:57:41Z | - |
dc.date.available | 2021-08-30T02:57:41Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2021-02-19 | - |
dc.identifier.issn | 0006-291X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/49559 | - |
dc.description.abstract | Methylene blue (MB) is a blue cationic thiazine dye and currently used in different medical settings. Notably, there have been several attempts to introduce MB for attenuating pain in the last decade. Some clinical studies reported remarkable results, which, however, have been much debated. In addition, accumulating evidence have revealed that MB diminishes voltage-gated sodium channel currents. Accordingly, in the present study, we conducted in vivo experiments, including in vivo single nerve recording and behavioral test, to investigate whether MB dampens neural firing rates and ultimately contributes to pain relief. As a result, neural firing rates significantly decreased and finally converged to zero after MB administration. This event lasted longer than that of lidocaine and was dose-dependently modulated. Furthermore, there was a marked improvement in pain behaviors. The withdrawal threshold and latency of hind paws significantly rose post-MB administration. Therefore, these results demonstrate that MB lessens pain by significantly weakening neural excitability, which implies a strong possibility that this dye may be developed as a pain-relieving medication in the future. This is the first in vivo study to elucidate the effect of MB on nerves and pain relief. (C) 2021 Elsevier Inc. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.title | Methylene blue induces an analgesic effect by significantly decreasing neural firing rates and improves pain behaviors in rats | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Seung Won | - |
dc.contributor.affiliatedAuthor | Park, Jin Sung | - |
dc.contributor.affiliatedAuthor | Han, Hee Chul | - |
dc.identifier.doi | 10.1016/j.bbrc.2021.01.008 | - |
dc.identifier.scopusid | 2-s2.0-85099296355 | - |
dc.identifier.wosid | 000615714500006 | - |
dc.identifier.bibliographicCitation | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, v.541, pp.36 - 42 | - |
dc.relation.isPartOf | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
dc.citation.title | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
dc.citation.volume | 541 | - |
dc.citation.startPage | 36 | - |
dc.citation.endPage | 42 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biophysics | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biophysics | - |
dc.subject.keywordAuthor | Methylene blue | - |
dc.subject.keywordAuthor | Lidocaine | - |
dc.subject.keywordAuthor | In vivo single nerve recording | - |
dc.subject.keywordAuthor | Neural firing rate | - |
dc.subject.keywordAuthor | Pain reduction | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.